Jacobs Levy Equity Management, Inc Charles River Laboratories International, Inc. Transaction History

Jacobs Levy Equity Management, Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$125.07 - $143.67 $1.6 Million - $1.84 Million	-12,776 Closed	0 $0
Q2 2019 Aug 13, 2019	SELL	$123.4 - $148.55 $12,340 - $14,855	-100 Reduced 0.78%	12,776 $1.81 Million
Q1 2019 May 14, 2019	SELL	$104.82 - $146.73 $5.22 Million - $7.3 Million	-49,766 Reduced 79.45%	12,876 $1.87 Million
Q4 2018 Feb 14, 2019	SELL	$105.09 - $137.23 $11,559 - $15,095	-110 Reduced 0.18%	62,642 $7.09 Million
Q3 2018 Nov 14, 2018	BUY	$112.11 - $134.54 $4.7 Million - $5.64 Million	41,922 Added 201.26%	62,752 $8.44 Million
Q2 2018 Aug 14, 2018	BUY	$102.37 - $117.25 $1.73 Million - $1.99 Million	16,930 Added 434.1%	20,830 $2.34 Million
Q1 2018 May 15, 2018	BUY	$98.19 - $115.2 $382,941 - $449,280	3,900 New	3,900 $416,000

691

51.6M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $8.38B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.